Showing results (261-270 of 301) with videos related to
Sort By:
Pageof 31
Biochemical and Biophysical Research Communications|July 20, 2002
SVK14 cells express an MCH binding site different from the MCH1 or MCH2 receptorValérie Audinot, Chantal Lahaye, Thomas Suply, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|February 6, 2004
A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptorO Della-Zuana, L Revereault, A Beck-Sickinger, et al.Biochemical Pharmacology|November 19, 2005
Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzymeFrançois Mailliet, Gilles Ferry, Fanny Vella, et al.Synapse (New York, N.Y.)|December 28, 1999
Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive statesM J Millan, A Newman-Tancredi, V Audinot, et al.Journal of Medicinal Chemistry|September 4, 2015
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolinesGilberto Spadoni, Annalida Bedini, Simone Lucarini, et al.Protein Science : a Publication of the Protein Society|September 28, 2016
Total chemical synthesis, refolding, and crystallographic structure of fully active immunophilin calstabin 2 (FKBP12.6)Marine Bacchi, Magali Jullian, Serena Sirigu, et al.Journal of Pineal Research|July 7, 2007
Detection of the human GPR50 orphan seven transmembrane protein by polyclonal antibodies mapping different epitopesHassina Ould Hamouda, Patty Chen, Angélique Levoye, et al.The Journal of Pharmacology and Experimental Therapeutics|May 18, 2001
Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterizationM J Millan, D Cussac, G Milligan, et al.The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profileM J Millan, A Gobert, A Newman-Tancredi, et al.The Journal of Biological Chemistry|March 18, 2000
Substrate specificity and inhibition studies of human serotonin N-acetyltransferaseG Ferry, A Loynel, N Kucharczyk, et al.Pageof 31